… affected by this, all over the world. It is more prevalent in middle to low-income countries. Almost 12% of global health expenditure is spent on diabetes. Advances in technological innovation and approval of artificial pancreas have help in …
… affected by this, all over the world. It is more prevalent in middle to low-income countries. Almost 12% of global health expenditure is spent on diabetes. Advances in technological innovation and approval of artificial pancreas have help in …